medigraphic.com
ISSN 0035-0052 (Print)

2003, Number 1

<< Back Next >>

Rev Mex Pediatr 2003; 70 (1)

Associated factors for blood transfusion in critically ill neonates

López CC, Eguigurems ZI, Valencia SG, Chang YA, Rodríguez WMA

Language: Spanish
References: 18
Page: 10-13
PDF size: 49.12 Kb.


ABSTRACT

The normal hemoglobin fall associated diseases and blood withdrawal for laboratory test are factors that allow to transfusions in newborns. We performed this study to know the quantity and kind of blood products transfunded to ill newborns.
We recorded all blood products administered to newborns and blood withdrawal quantity in a neonatal intensive care unit. We studied 84 patients; 56% were transfunded. In this group, the mean gestational age was 36 weeks, the birth weight was 2,438 g. An average of 4.4 transfusions were applied to the patients in the group; it was a mean volume of 144 mL (63 mL/kg) and it were required 3.8 blood donors for each baby. The mean blood withdrawal was 23.6 mL/kg among transfunded infants versus 7.5 mL/kg among not transfunded ones. Red blood cell transfusions correlated with hospitalary staying. Donors quantity required for each baby depends of number of transfusions. We concluded that we must reduce the blood withdrawal and the hospitalary staying in order to decrease transfusions and their risks.


REFERENCES

  1. Salsbury DC. Anemia of prematurity. Neonatal Netw 2001; 20: 13-20.

  2. Obladen M, Diepold K, Maier RF. European Multicenter rhEPO Study Group. Venous and arterial hematologic profiles of very low birth weight infants. Pediatrics 2000; 106: 707-11.

  3. Jurado GE, Álvarez CJ, Díaz BS, Aguado FC, Parra JS. Consideraciones sobre los valores “normales” de la hemoglobina y del hematócrito durante la etapa neonatal del niño prematuro. Bol Med Hosp Infant Mex 1968: 37-49.

  4. Dear P. Blood transfusion in the preterm infant. Arch Dis Child 1984; 59: 296-8.

  5. Manno CS, Friedman DF. Transfusion therapy. In: Spitzer AR: Intensive care of the fetus and neonate. Mosby, St. Louis MO; 1996: 1127-39.

  6. Strauss RG. Red blood cell transfusion practices in the neonate. Clin Perinatol 1995; 22: 641-55.

  7. Sacher RA, Luban NLC, Strauss RG. Current practice and guidelines for the transfusion of cellular blood components in the newborn. Transfus Med Rev 1989; 3: 39-54.

  8. Blanchette VS, Hurne HA, Levy GJ, Luban NL, Strauss RG. Guidelines for auditing pediatric blood transfusion practices. Am J Dis Child 1991; 145: 787-96.

  9. Kling PJ, Sullivan TM, Leftwich ME, Roe DJ. Score for neonatal acute physiology and phlebotomy blood loss predict erythrocyte transfusions in premature infants. Arch Pediatr Adolesc Med 1997; 151: 27-31.

  10. López-Candiani C, Chang-Yui AL, Rodríguez-Weber MA, Valencia-Salazar G, Eguigurems-Zamora I. Factores que influyen en la extracción sanguínea a pacientes hospitalizados en una terapia intensiva neonatal. Bol Med Hosp Infant Mex 2002; 59: 159-65.

  11. Maier RF, Obladen M, Muller-Hansen I, Kattner E, Merz U et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1,000 g. J Pediatr 2002; 141: 8-15.

  12. García MG, Hutson AD, Christensen RD. Effect of recombinant erythropoietin on “late” transfusions in the neonatal intensive care unit: a meta-analysis. J Perinatol 2002; 22: 108-11.

  13. Maes LY, Southgate WM, Wagstaff P, Eicher DJ, Reilly N et al. A successful multidisciplinary approach to the reduction of transfusion and donor exposures in the extremely low birth weight infant. Transfusion 2001; 41 (Suppl): 93S.

  14. Sherry TJ, Kanter MH, Spencer CM. A quality improvement project to decrease donor exposures for neonates using multiple interventions including erythropoietin. Transfusion 2001; 41 (Suppl): 92S-3S.

  15. Bravo LA, Romero LD. Tratamiento transfusional. En: Instituto Nacional de Pediatría (ed). Manual de Pediatría. México D.F.: Mc Graw Hill-Interamericana, 1999.

  16. Consenso de Expertos en Medicina Transfusional. Recomendaciones para la terapia transfusional de sangre y sus componentes. México D.F.: Agrupación Mexicana para el Estudio de la Hematología, 2001.

  17. Franz AR, Pohlandt F. Red blood cell transfusions in very and extremely low birthweight infants under restrictive transfusion guidelines: is exogenous erythropoietin necessary? Arch Dis Child Fetal Neonatal Ed 2001; 84: F96-F100.

  18. Strauss RG. Transfusion therapy in neonates. Am J Dis Child 1991; 145: 904-11.




2020     |     www.medigraphic.com